https://www.aveooncology.com Oncology Thu, 03 Oct 2019 16:11:24 +0000 en-US hourly 1 https://wordpress.org/?v=4.1.27 https://www.aveooncology.com/news/aveo-oncology-announces-initiation-of-enrollment-in-phase-1b2-study-of-fotivda-tivozanib-in-combination-with-imfinzi-durvalumab-in-previously-untreated-metastatic-hepatocellular-carci/ https://www.aveooncology.com/news/aveo-oncology-announces-initiation-of-enrollment-in-phase-1b2-study-of-fotivda-tivozanib-in-combination-with-imfinzi-durvalumab-in-previously-untreated-metastatic-hepatocellular-carci/#comments Mon, 30 Sep 2019 11:05:18 +0000 https://www.aveooncology.com/?p=1734 AVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma
September 30, 2019

]]> https://www.aveooncology.com/news/aveo-oncology-announces-initiation-of-enrollment-in-phase-1b2-study-of-fotivda-tivozanib-in-combination-with-imfinzi-durvalumab-in-previously-untreated-metastatic-hepatocellular-carci/feed/ 0 https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-cantor-fitzgerald-global-healthcare-conference/ https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-cantor-fitzgerald-global-healthcare-conference/#comments Thu, 26 Sep 2019 11:05:52 +0000 https://www.aveooncology.com/?p=1729 AVEO Oncology to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 26, 2019

]]> https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-cantor-fitzgerald-global-healthcare-conference/feed/ 0 https://www.aveooncology.com/events/aveo-oncology-at-2019-cantor-fitzgerald-global-healthcare-conference/ https://www.aveooncology.com/events/aveo-oncology-at-2019-cantor-fitzgerald-global-healthcare-conference/#comments Thu, 26 Sep 2019 11:05:33 +0000 https://www.aveooncology.com/?p=1731 AVEO Oncology at 2019 Cantor Fitzgerald Global Healthcare Conference
Friday, October 4, 2019

]]> https://www.aveooncology.com/events/aveo-oncology-at-2019-cantor-fitzgerald-global-healthcare-conference/feed/ 0 https://www.aveooncology.com/news/aveo-oncology-and-eusa-pharma-announce-presentation-of-final-pfs-results-from-phase-2-portion-of-the-tinivo-study-in-renal-cell-carcinoma/ https://www.aveooncology.com/news/aveo-oncology-and-eusa-pharma-announce-presentation-of-final-pfs-results-from-phase-2-portion-of-the-tinivo-study-in-renal-cell-carcinoma/#comments Mon, 23 Sep 2019 11:00:13 +0000 https://www.aveooncology.com/?p=1726 AVEO Oncology and EUSA Pharma Announce Presentation of Final PFS Results from Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma

September 23, 2019

]]> https://www.aveooncology.com/news/aveo-oncology-and-eusa-pharma-announce-presentation-of-final-pfs-results-from-phase-2-portion-of-the-tinivo-study-in-renal-cell-carcinoma/feed/ 0 https://www.aveooncology.com/news/aveo-oncology-announces-updated-overall-survival-hazard-ratio-of-0-99-in-phase-3-tivo-3-trial-of-tivozanib-in-renal-cell-carcinoma/ https://www.aveooncology.com/news/aveo-oncology-announces-updated-overall-survival-hazard-ratio-of-0-99-in-phase-3-tivo-3-trial-of-tivozanib-in-renal-cell-carcinoma/#comments Tue, 10 Sep 2019 10:35:59 +0000 https://www.aveooncology.com/?p=1718 AVEO Oncology Announces Updated Overall Survival Hazard Ratio of 0.99 in Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma
September 10, 2019

]]> https://www.aveooncology.com/news/aveo-oncology-announces-updated-overall-survival-hazard-ratio-of-0-99-in-phase-3-tivo-3-trial-of-tivozanib-in-renal-cell-carcinoma/feed/ 0 https://www.aveooncology.com/events/tivo-3-os-update-call/ https://www.aveooncology.com/events/tivo-3-os-update-call/#comments Tue, 10 Sep 2019 10:35:45 +0000 https://www.aveooncology.com/?p=1720 TIVO-3 OS Update Call
Tuesday, September 10, 2019

]]> https://www.aveooncology.com/events/tivo-3-os-update-call/feed/ 0 https://www.aveooncology.com/news/aveo-reports-second-quarter-2019-financial-results-and-provides-business-update/ https://www.aveooncology.com/news/aveo-reports-second-quarter-2019-financial-results-and-provides-business-update/#comments Thu, 08 Aug 2019 11:10:54 +0000 https://www.aveooncology.com/?p=1699 AVEO Reports Second Quarter 2019 Financial Results and Provides Business Update
August 8, 2019

]]> https://www.aveooncology.com/news/aveo-reports-second-quarter-2019-financial-results-and-provides-business-update/feed/ 0 https://www.aveooncology.com/news/kyowa-kirin-buys-back-tivozanib-non-oncology-rights-from-aveo-oncology/ https://www.aveooncology.com/news/kyowa-kirin-buys-back-tivozanib-non-oncology-rights-from-aveo-oncology/#comments Thu, 01 Aug 2019 10:14:27 +0000 https://www.aveooncology.com/?p=1693 Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO Oncology
August 1, 2019

]]> https://www.aveooncology.com/news/kyowa-kirin-buys-back-tivozanib-non-oncology-rights-from-aveo-oncology/feed/ 0 https://www.aveooncology.com/events/2019-bio-international-convention/ https://www.aveooncology.com/events/2019-bio-international-convention/#comments Wed, 29 May 2019 11:10:58 +0000 https://www.aveooncology.com/?p=1687 2019 BIO International Convention
Wednesday, June 5, 2019

]]> https://www.aveooncology.com/events/2019-bio-international-convention/feed/ 0 https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-bio-international-convention/ https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-bio-international-convention/#comments Wed, 29 May 2019 11:10:36 +0000 https://www.aveooncology.com/?p=1689 AVEO Oncology to Present at the 2019 BIO International Convention
May 29, 2019

]]> https://www.aveooncology.com/news/aveo-oncology-to-present-at-the-2019-bio-international-convention/feed/ 0